Antigen-specific active immunotherapy for ovarian cancer

"Antigen-specific active immunotherapy for ovarian cancer is not supported by sufficient good quality evidence. Consideration could be given to using it only within the context of a research or audit project.

Reducing or stopping antigen-specific active immunotherapy for ovarian cancer is likely to improve the quality of patient care by reducing exposure to unproven therapies and result in productivity savings."

Antigen-specific active immunotherapy for ovarian cancer (Quality and productivity collection examples)
The UK Cochrane Centre and NICE
November 2014

Read more here.

NICE clinical case scenarios

Clinical case scenarios are an educational resource that can be used for individual or group learning. Each question should be considered by the individual or group before referring to the answers.The resource is available in a PDF document for individual learning or as a power point presentation to help facilitate group learning.

Here is a list of clinical case scenarios that are currently available:

• CG108 Chronic heart failure
• CG113 Anxiety
• CG122 Ovarian cancer
• CG123 Common mental health disorders
• CG126 Stable angina: chest pain algorithm
• CG127 Hypertension
• CG131 Colorectal cancer
• CG133 Self-harm (longer-term management) 
• CG135 Organ donation
• CG137 Epilepsy